Divis Laboratories reports 4.38% rise in Q1 net profit

05 Aug 2013 Evaluate

Divis Laboratories has reported results for first quarter ended June 30, 2013.

On standalone basis, the company has posted a rise of 4.38% in its net profit at Rs 174.71 crore for the quarter ended June 30, 2013 as compared to Rs 167.38 crore for the same quarter in the previous year. The total income of the company has increased by 11.84% to Rs 570.57 crore for quarter under review as compared to Rs 510.17 crore for the quarter ended June 30, 2012.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

5863.00 -33.90 (-0.57%)
08-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.30
Dr. Reddys Lab 1370.60
Cipla 1495.05
Lupin 2252.40
Zydus Lifesciences 981.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.